Editorial: Survival and the sentinel lymph node in melanoma

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 18-20

  Faries, Mark ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRASTUZUMAB;

CANCER MORTALITY; CANCER PATIENT; CANCER SIZE; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG EFFICACY; EDITORIAL; ELECTIVE SURGERY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PROGNOSIS; RISK REDUCTION; SENTINEL LYMPH NODE; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR RECURRENCE; LYMPH NODE; LYMPHADENECTOMY; MORTALITY; NOTE; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MELANOMA; SENTINEL LYMPH NODE BIOPSY;

EID: 74649084039     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0782-0     Document Type: Editorial

References (11)

1. SA Rosenberg 2008 Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol 5 1 10.1038/ncponc1022 18097452
2. DL Morton AJ Cochran JF Thompson 2007 Authors' response to a letter to the editor re: sentinel node biopsy for early-stage melanoma Ann Surg 245 828 829 10.1097/01.sla.0000261157.79250.16 17457182 (Pubitemid 46684119)
3. DL Morton JF Thompson AJ Cochran, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 1317 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D 17005948 (Pubitemid 44465459)
4. D Morton D Hoon A Cochran, et al. 2003 Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg 238 538 549 14530725
5. JC Kang LA Wanek R Essner, et al. 2005 Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma J Clin Oncol 23 4764 4770 10.1200/JCO.2005.20.537 16034052 (Pubitemid 46224080)
6. TM Pawlik MI Ross JF Thompson, et al. 2005 The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes J Clin Oncol 23 4588 4590 10.1200/JCO.2005.12.245 16034040 (Pubitemid 46224060)
7. CM Balch SJ Soong AA Bartolucci, et al. 1996 Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann Surg 224 255 263 10.1097/00000658-199609000-00002 1:STN:280:DyaK28vgvVajuw%3D%3D 8813254 discussion 263-6 (Pubitemid 26307468)
8. AC van Akkooi ZI Nowecki C Voit, et al. 2008 Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes Ann Surg 248 949 955 10.1097/SLA.0b013e31818fefe0 19092339
9. L Kretschmer R Hilgers 2006 Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma J Clin Oncol 24 2965 2966 10.1200/JCO.2006.06.5854 16782937 (author reply 2966-7) (Pubitemid 46630603)
10. JH Lee R Essner H Torisu-Itakura, et al. 2004 Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 3677 3684 10.1200/JCO.2004.01.012 15365064 (Pubitemid 41095206)
11. JW Jakub M Huebner S Shivers, et al. 2009 The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node Ann Surg Oncol 16 2245 2251 10.1245/s10434-009-0530-5 19517194